220 likes | 450 Views
第十二章 超敏反应. 中国科学院上海生命科学院 上海巴斯德研究所 孙兵教授 (Sun Bing, MD, Ph.D) 电话 :63851927, E-mail:bsun@sibs.ac.cn. INTRODUCTION TO ALLERGY.
E N D
第十二章 超敏反应 中国科学院上海生命科学院 上海巴斯德研究所 孙兵教授(Sun Bing, MD, Ph.D) 电话:63851927, E-mail:bsun@sibs.ac.cn
INTRODUCTION TO ALLERGY • Hypersensitivity: Initially, human being contacts Ag (allergy) and becomes sensitization. Then the body has a high response to same allergy when it contacts with them in second time (through skin, mucosal or blood).
THE IMMUNE SYSTEM CAN GO WRONG IN SEVERAL WAYS • Gell and Coomb’s classification of hypersensitivity (type I, II, III and IV) • “Allergy” is the commonest way that the immune system can go wrong
GELL AND COOMB’SCLASSIFICATION OF THE HYPERSENSITIVIY STATES • TYPE 1 - IgE Ab mediated immediate reaction • TYPE 2 - IgG, M mediated Ab response • TYPE 3 - Immune complex • TYPE 4 - Delayed type hypersensitivity
TB response ABO-red blood type Rhsus disease/Rh-M/with Rh+child Ab positive treatment
General mechanism underlying a type I hypersensitive reaction.
Components of Type I Reactions • ALLERGENS • REAGINIC ANTIBODY (IgE) • MAST CELLS AND BASOPHILS • IgE-BINDING Fc RECEPTORS
When a substance is capable of producing allergic symptoms, it is known as an allergen.
TH2 CELLS • Produce interleukins-4,5,10,13 • Important in inhibition of macrophage activation • Important in the the development of IgE responses (IL-4/IL-13) • Important in development of eosinophilia (IL-5)
IgE Cross-linkage and Mast Cell Activation/Degranulation Antigen IgE Fc Receptor
Late-Phase Reactions Induce Localized Inflammatory Reactions
Type I Responses Are Regulated by Many Factors Antigen dosage Repeated low doses of an appropriate antigen induce a persistent IgE response in mice, but higher antigen doses result in transient IgE production and a shift toward IgG.
Therapeutic strategies for allergic diseases Dissociation of anti-inflammatory effects from side effects of corticosteroids.
Inhibition of antigen-presenting cells (APCs) and Th2 lymphocytes.
Inhibition of eosinophilic inflammation. Anti-histamine drug and immune modulator from Th2 switching to Th1.